Literature DB >> 17671758

Validity of endoscopic classification of nonerosive reflux disease.

Takashi Joh1, Hiroto Miwa, Kazuhide Higuchi, Tomohiko Shimatani, Noriaki Manabe, Kyoichi Adachi, Tsuneya Wada, Makoto Sasaki, Yasuhiro Fujiwara, Michio Hongo, Tsutomu Chiba, Yoshikazu Kinoshita.   

Abstract

BACKGROUND: Minimal changes, such as erythema without sharp demarcation or whitish turbidity of the lower esophageal mucosa, have recently been used for endoscopic classification of nonerosive reflux disease (NERD) in Japan. This study examined the usefulness of such changes in characterizing the pathophysiology of NERD.
METHODS: Physicians specializing in esophageal endoscopy performed endoscopy on 115 patients with NERD. Based on the presence or absence of minimal changes, patients were categorized as displaying NERD with minimal changes (grade M, n = 49) or with no minimal changes or mucosal breaks (grade N, n = 66). Clinical features, quality of life (QOL) scores, and ambulatory 24-h esophageal pH values were compared between groups. Ambulatory 24-h esophageal pH values were monitored in 31 patients (14 grade M and 17 grade N patients) who gave consent out of 115 patients.
RESULTS: In ambulatory 24-h esophageal pH monitoring, 57.1% (8/14) of grade M patients had pH < 4 more than 4% of the time (abnormal acid reflux) compared with 11.8% (2/17) in the grade N group, a significant difference (P = 0.018). QOL scores did not differ significantly between grades and were significantly lower in both groups compared with the general Japanese population. No significant differences were observed in patient background between the grade M and grade N groups.
CONCLUSIONS: Frequency of abnormal acid reflux with NERD is higher in patients with minimal changes than in patients without such changes. Minimal changes are most likely attributable to gastric acid reflux.

Entities:  

Mesh:

Year:  2007        PMID: 17671758     DOI: 10.1007/s00535-007-2022-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  20 in total

1.  Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan.

Authors:  S Fukuhara; S Bito; J Green; A Hsiao; K Kurokawa
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

Review 2.  Nonerosive reflux disease--current concepts and dilemmas.

Authors:  R Fass; M B Fennerty; N Vakil
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

3.  Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis.

Authors:  C M Bate; J R Green; A T Axon; F E Murray; G Tildesley; C E Emmas; M D Taylor
Journal:  Aliment Pharmacol Ther       Date:  1997-08       Impact factor: 8.171

4.  Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese.

Authors:  Ikuyo Mishima; Kyoichi Adachi; Noriyuki Arima; Kazutoshi Amano; Toshiharu Takashima; Makoto Moritani; Kenji Furuta; Yoshikazu Kinoshita
Journal:  Scand J Gastroenterol       Date:  2005-09       Impact factor: 2.423

Review 5.  Minimal changes in reflux esophagitis: red ones and white ones.

Authors:  Michio Hongo
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

6.  Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan.

Authors:  Yasuhiro Fujiwara; Kazuhide Higuchi; Masatsugu Shiba; Kazuki Yamamori; Yoko Watanabe; Eiji Sasaki; Kazunari Tominaga; Toshio Watanabe; Nobuhide Oshitani; Tetsuo Arakawa
Journal:  Am J Gastroenterol       Date:  2005-04       Impact factor: 10.864

7.  Is there a set of histologic changes that are invariably reflux associated?

Authors:  Kaiyo Takubo; Naoko Honma; Gopi Aryal; Motoji Sawabe; Tomio Arai; Yasuo Tanaka; Ken-ichi Mafune; Katsuhiko Iwakiri
Journal:  Arch Pathol Lab Med       Date:  2005-02       Impact factor: 5.534

Review 8.  Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease.

Authors:  Ronnie Fass
Journal:  Am J Gastroenterol       Date:  2003-03       Impact factor: 10.864

Review 9.  [Endoscopic findings of GERD].

Authors:  Yoshio Hoshihara
Journal:  Nihon Rinsho       Date:  2004-08

10.  Symptom index as a marker of gastro-oesophageal reflux disease.

Authors:  B T Johnston; R J McFarland; J S Collins; A H Love
Journal:  Br J Surg       Date:  1992-10       Impact factor: 6.939

View more
  18 in total

1.  Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia.

Authors:  Yoshikazu Kinoshita; Hiroto Miwa; Katsuyuki Sanada; Koji Miyata; Ken Haruma
Journal:  J Gastroenterol       Date:  2013-05-08       Impact factor: 7.527

2.  Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic study.

Authors:  Kiyoshi Ashida; Yoshikazu Kinoshita; Michio Hongo
Journal:  Dig Dis Sci       Date:  2011-02-08       Impact factor: 3.199

3.  Comparison of acid inhibition with standard dosages of proton pump inhibitors in relation to CYP2C19 genotype in Japanese.

Authors:  Mitsushige Sugimoto; Naohito Shirai; Masafumi Nishino; Chise Kodaira; Takahiro Uotani; Shu Sahara; Hitomi Ichikawa; Takuma Kagami; Ken Sugimoto; Takahisa Furuta
Journal:  Eur J Clin Pharmacol       Date:  2014-07-06       Impact factor: 2.953

4.  Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study.

Authors:  Takayoshi Suzuki; Masashi Matsushima; Aya Masui; Shingo Tsuda; Jin Imai; Jun Nakamura; Yoko Tsukune; Tetsufumi Uchida; Hiroki Yuhara; Muneki Igarashi; Jun Koike; Tetsuya Mine
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

5.  Radially asymmetric gastroesophageal acid reflux in the distal esophagus: examinations with novel pH sensor catheter equipped with 8 pH sensors.

Authors:  Shunji Ohara; Kenji Furuta; Kyoichi Adachi; Shino Shimura; Kousuke Fukazawa; Masahito Aimi; Eisuke Okamoto; Yoshinori Komazawa; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2012-04-25       Impact factor: 7.527

6.  Gastro-esophageal reflux disease: the recent trend in Japan.

Authors:  Hiroto Miwa; Tadayuki Oshima; Toshihiko Tomita; Yongmin Kim; Kazutoshi Hori; Takayuki Matsumoto
Journal:  Clin J Gastroenterol       Date:  2008-12-02

7.  Brief Questioning by Nursing Staffs before Endoscopic Examination May Not Always Pick Up Clinical Symptoms of Endoscopic Reflux Esophagitis.

Authors:  Tooru Takashima; Kanako Yamaguchi; Megumi Hara; Tomoko Fukuda; Tsukasa Kuroki; Chie Furushima; Ruriko Wakeshima; Ryuichi Iwakiri; Kazuma Fujimoto; Norie Inoue
Journal:  J Clin Biochem Nutr       Date:  2010-04-10       Impact factor: 3.114

8.  A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease.

Authors:  Michio Hongo; Yoshikazu Kinoshita; Ken Haruma
Journal:  J Gastroenterol       Date:  2008-07-04       Impact factor: 7.527

9.  It is possible to classify non-erosive reflux disease (NERD) patients into endoscopically normal groups and minimal change groups by subjective symptoms and responsiveness to rabeprazole -- a report from a study with Japanese patients.

Authors:  Motoyasu Kusano; Naohito Shirai; Kanako Yamaguchi; Michio Hongo; Tsutomu Chiba; Yoshikazu Kinoshita
Journal:  Dig Dis Sci       Date:  2008-05-09       Impact factor: 3.199

Review 10.  Epidemiology and clinical characteristics of GERD in the Japanese population.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-04-14       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.